Skip to main contentSkip to navigation
Sirius Investors

Embecta Corp. (EMBC) Investment Research Dashboard

About Embecta Corp. (EMBC) stock analysis

Get live EMBC stock price $3.44, comprehensive Embecta Corp. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time EMBC stock data and investment insights.

3.44
4.41%Today
Market Cap
203.79M
Volume
862.32K
52W High
15.55
52W Low
2.77

Loading chart data...

Embecta Corp. (EMBC) Overview

Embecta Corp. (EMBC) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, EMBC trades at $3.44 with a market capitalization of 203.79M . Over the past 52 weeks, EMBC has traded between $2.77 and $15.55 , with the current price positioned at approximately 5% of this range . The stock ...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 203.79M
  • Current price: $3.44
  • 52-week range: $2.77 - $15.55
  • P/E ratio: 1.32

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanc...

Company Information

CEO
Devdatt Kurdikar
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1850

Contact Information

Address
300 Kimball Drive
Country
US

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 1.3)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Embecta Corp. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Embecta Corp.
  • Investors should consider how Embecta Corp. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

203.79M

P/E Ratio (TTM)

1.32

Beta

0.81

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

72/100 ⭐⭐⭐⭐⭐

Overall
-0.1%
NYSE
-0.1%
NASDAQ
-0.1%
Sector1D1W1MP/EScore
Consumer Defensive+1.3%+3.3%+2.2%29.2
88/100⭐⭐⭐⭐⭐
Financial Services-0.1%+0.9%+2.0%19.3
86/100⭐⭐⭐⭐⭐
Communication Services+0.4%-1.6%+2.0%22.2
74/100⭐⭐⭐⭐⭐
Healthcare-0.1%+0.5%+0.8%23.5
72/100⭐⭐⭐⭐⭐
Basic Materials-0.7%+0.1%-1.3%24.9
60/100⭐⭐⭐⭐
Energy-0.4%-2.0%-2.4%19.4
51/100⭐⭐⭐
Utilities-1.5%-0.5%-4.9%25.4
40/100⭐⭐⭐
Real Estate-1.6%-1.1%-3.5%29.4
36/100⭐⭐
Industrials-0.4%-0.5%-10.7%30.5
19/100
Consumer Cyclical-0.3%-2.3%-6.5%43.1
17/100
Technology-1.9%-4.0%-9.4%41.9
7/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.